VISIPAQUE iodixanol 5.5g/10mL (550mg/mL) injection ampoule Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 5.5g/10ml (550mg/ml) injection ampoule

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate; hydrochloric acid; sodium chloride; trometamol; sodium hydroxide; calcium chloride dihydrate - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 110g/200mL (550mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 110g/200ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; sodium calcium edetate; sodium chloride; water for injections; sodium hydroxide; calcium chloride dihydrate; trometamol - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 82.5g/150mL (550mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 82.5g/150ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; calcium chloride dihydrate; trometamol; water for injections; sodium calcium edetate - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 55g/100mL (550mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 55g/100ml (550mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 550 mg/ml - injection, solution - excipient ingredients: water for injections; calcium chloride dihydrate; sodium calcium edetate; trometamol; sodium hydroxide; hydrochloric acid; sodium chloride - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 130.4g/200mL (652mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 130.4g/200ml (652mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: trometamol; hydrochloric acid; sodium chloride; calcium chloride dihydrate; sodium calcium edetate; water for injections; sodium hydroxide - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 97.8g/150mL (652mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 97.8g/150ml (652mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; sodium chloride; calcium chloride dihydrate; water for injections; trometamol; sodium hydroxide; hydrochloric acid - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

VISIPAQUE iodixanol 65.2g/100mL (652mg/mL) injection bag Ástralía - enska - Department of Health (Therapeutic Goods Administration)

visipaque iodixanol 65.2g/100ml (652mg/ml) injection bag

ge healthcare australia pty ltd - iodixanol, quantity: 652 mg/ml - injection, solution - excipient ingredients: sodium calcium edetate; trometamol; sodium chloride; hydrochloric acid; calcium chloride dihydrate; sodium hydroxide; water for injections - this medicinal product is for diagnostic use only. visipaque is indicated in adult patients for angiocardiography, peripheral arteriography, visceral arteriography, cerebral arteriography, contrast-enhanced computed tomography of the head and body, excretory urography and venography. in arteriography, visipaque may be used for both conventional radiography and digital subtraction angiography (dsa). in children, visipaque is indicated for cardioangiography, urography, ct enhancement and studies of the upper gastrointestinal tract.

ARTERIAL AORTIC CANNULA - Cannula, arterial Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arterial aortic cannula - cannula, arterial

livanova australia pty ltd - 34893 - cannula, arterial - arterial cannula inserted into aortic arch or major vessels to deliver the oxygenated blood from heart-lung machine into the circulatory system of the patient.the bent tip terminating with a collar is for suturing. intended to deliver the oxygenated blood from the heart-lung machine into the circulatory system of the patient

Arterial blood sampling kit Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arterial blood sampling kit

bosco medical australia - 31336 - arterial blood sampling kit - radiopaque arterial catheter kit for measurement and diagnosis is suited for non-traumatic puncture of peripheral arteries for safe and complication-free positioning. it can be applied for any operation where a continuous blood pressure monitoring in anaesthesia and internal medicine is required and vessel damage or bleeding is to be eliminated, especially for arteria radialis, arteria brachialis and arteria femoralis. radiopaque arterial catheter is also suited for monitoring of the heart function, circulation and lung function control as well as for sampling of blood gas.

Arteriovenous shunt Ástralía - enska - Department of Health (Therapeutic Goods Administration)

arteriovenous shunt

emergo asia pacific pty ltd t/a emergo australia - 13586 - arteriovenous shunt - intended for the creation of a bridge graft for vascular access subsequent to at least one previously failed prosthetic access graft. a surgically-implanted device designed to provide a passage for blood to flow between an artery typically located in an arm, and a peripheral vein, central vein or right atrium, creating a graft fistula that provides blood access for external procedures, especially hemodialysis. it is a synthetic vascular graft/graft assembly with a thin wall and appropriate size (commonly 6 mm diameter) and configuration to facilitate vessel puncturing. it is typically used when it is not possible or convenient to create a direct arteriovenous fistula or for patients who have exhausted peripheral venous access. disposable devices associated with implantation may be included. storage solution is buffered saline. this is a single-use device.